Inventor · disambiguated record
Raphael Mechoulam
Also filed as: DIKSTEIN SHABTAY · KLOOG YOEL · MECHOULAM RAPHAEL
43 granted patents·17 pending applications·1,294 citations·filing 1976–2021
98Inventor score
Files withYISSUM RES DEV CO31YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD10MECHOULAM RAPHAEL6EPM IP INC2UNIV RAMOT2
Top patents by PatentIndex Score
60 records- 0196US5434295ANeuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compoundsYISSUM RES DEV CO·Filed 1994·Granted Jul 18, 1995·91 cites·33 claims
- 0295US5538993ACertain tetrahydrocannabinol-7-oic acid derivativesYISSUM RES DEV CO·Filed 1994·Granted Jul 23, 1996·115 cites·24 claims
- 0395US4282248APinene derivatives and pharmaceutical compositions containing the sameMECHOULAM RAPHAEL·Filed 1979·Granted Aug 4, 1981·61 cites·12 claims
- 0494US4876276A(3S-4S)-7-hydroxy-Δ6 -tetrahydrocannabinolsYISSUM RES DEV CO·Filed 1987·Granted Oct 24, 1989·111 cites·10 claims
- 0593US5635530A(3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing themYISSUM RES DEV CO·Filed 1992·Granted Jun 3, 1997·75 cites·9 claims
- 0693US5338753A(3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesicsBURSTEIN SUMNER H·Filed 1992·Granted Aug 16, 1994·92 cites·18 claims
- 0791US8119697B2Anti-nausea and anti-vomiting activity of cannabidiol compoundsMECHOULAM RAPHAEL·Filed 2006·Granted Feb 21, 2012·25 cites·15 claims
- 0891US5618955AFatty acid derivatives and pharmaceutical compositions containing sameYISSUM RES DEV CO·Filed 1993·Granted Apr 8, 1997·85 cites·9 claims
- 0991US4179517ANovel tetrahydrocannabinol type compoundsYISSUM RES DEV CO·Filed 1976·Granted Dec 18, 1979·64 cites·15 claims
- 1090US9447019B2Fluorinated CBD compounds, compositions and uses thereofYISSUM RES DEV CO·Filed 2014·Granted Sep 20, 2016·21 cites·10 claims
- 1190US6096740ADexanabinol derivatives and their use as neuroprotective pharmaceutical compositionsUNIV RAMOT·Filed 1995·Granted Aug 1, 2000·77 cites·36 claims
- 1289US9782360B2Fluorinated CBD compounds, compositions and uses thereofYISSUM RES DEV CO·Filed 2016·Granted Oct 10, 2017·12 cites·14 claims
- 1386US8071641B2Treating or preventing diabetes with cannabidiolWEISS LOLA·Filed 2005·Granted Dec 6, 2011·28 cites·5 claims
- 1486US6903137B2Agonists specific for the peripheral cannabinoid receptorYISSUM RES DEV CO·Filed 2002·Granted Jun 7, 2005·28 cites·13 claims
- 1586US6864291B1Agonists specific for the peripheral cannabinoid receptorYISSUM RES DEV CO·Filed 2000·Granted Mar 8, 2005·27 cites·20 claims
- 1686US5932610ATumor necrosis factor α (TNF-α) inhibiting pharmaceuticalsYISSUM RES DEV CO·Filed 1996·Granted Aug 3, 1999·63 cites·16 claims
- 1786US5521215ANMDA-blocking pharmaceuticalsUNIV RAMOT·Filed 1994·Granted May 28, 1996·85 cites·8 claims
- 1883US7214716B2Agonists specific for the peripheral cannabinoid receptorYISSUM RES DEV CO·Filed 2005·Granted May 8, 2007·7 cites·11 claims
- 1979US7759526B2Pharmaceutical compositions comprising cannabidiol derivativesYISSUM RES DEV CO·Filed 2001·Granted Jul 20, 2010·18 cites·5 claims
- 2078US5284867ANMDA-blocking pharmaceutical compositionsYISSUM RES DEV CO·Filed 1992·Granted Feb 8, 1994·57 cites·18 claims
- 2177US6566543B22-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injuryYISSUM RES DEV CO·Filed 2001·Granted May 20, 2003·14 cites·8 claims
- 2277US6410588B1Use of cannabinoids as anti-inflammatory agentsKENNEDY RHEUMATOLOGY INST·Filed 1999·Granted Jun 25, 2002·43 cites·7 claims
- 2376US10239848B2Cyclohexenyl compounds, compositions comprising them and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2017·Granted Mar 26, 2019·1 cites·19 claims
- 2476US8722938B2Arylated camphenes, processes for their preparation and uses thereofMECHOULAM RAPHAEL·Filed 2010·Granted May 13, 2014·4 cites·12 claims
- 2576US8497299B2Compositions including quinonoid derivatives of cannabinoids for therapeutic useMECHOULAM RAPHAEL·Filed 2005·Granted Jul 30, 2013·11 cites·17 claims
- 2676US6545041B2Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticalsYISSUM RES DEV CO·Filed 2001·Granted Apr 8, 2003·8 cites·18 claims
- 2775US6531636B1Synthetic endogenous cannabinoids analogues and uses thereofYISSUM RES DEV CO·Filed 2000·Granted Mar 11, 2003·8 cites·20 claims
- 2872US11149014B2Method for treating pain or associated condition or symptomYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2019·Granted Oct 19, 2021·0 cites·12 claims
- 2971US8198327B2Fatty acid amides and uses thereofMECHOULAM RAPHAEL·Filed 2009·Granted Jun 12, 2012·3 cites·14 claims
- 3070US9428431B2Compositions comprising CB receptor agonists, uses thereof and methods for their preparationBAB ITAI·Filed 2009·Granted Aug 30, 2016·2 cites·14 claims
- 3169US9365534B2Arylated camphenes, processes for their preparation and uses thereofYISSUM RES DEV CO·Filed 2014·Granted Jun 14, 2016·1 cites·4 claims
- 3268US6331560B1Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticalsYISSUM RES DEV CO·Filed 1999·Granted Dec 18, 2001·21 cites·13 claims
- 3367US11058652B2Methods for treatment of Prader-Willi syndromeYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2017·Granted Jul 13, 2021·1 cites·16 claims
- 3466US4707559AAnalgetic and antiemetic compositionsMECHOULAM RAPHAEL·Filed 1986·Granted Nov 17, 1987·8 cites·12 claims
- 3565US10166202B2Treatment of hepatic encephalopathy and liver cirrhosisBERRY ELLIOT·Filed 2011·Granted Jan 1, 2019·1 cites·4 claims
- 3665US7749953B2Methods compositions and articles of manufacture for modulating bone growthYISSUM RES DEV CO·Filed 2004·Granted Jul 6, 2010·2 cites·9 claims
- 3764US7884133B2Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivativesYISSUM RES DEV CO·Filed 2004·Granted Feb 8, 2011·2 cites·4 claims
- 3864US5605928AAntiemetic compositionsYISSUM RES DEV CO·Filed 1993·Granted Feb 25, 1997·22 cites·6 claims
- 3961US2010022631A1Treatment of hepatic encephalopathy and liver cirrhosisYISSUM RES DEV CO·Filed 2009·Application pending·0 cites
- 4057US12403114B2Cannabinoid acid ester compositions and uses thereofEPM IP INC·Filed 2020·Granted Sep 2, 2025·0 cites·20 claims
- 4157US7407753B2Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosisYISSUM RES DEV CO·Filed 2004·Granted Aug 5, 2008·0 cites·1 claims
- 4256US2022000814A1Methods for treatment of prader-willi syndromeYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2021·Application pending·0 cites
- 4355US10441553B2Fluorinated CBD compounds, compositions and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2017·Granted Oct 15, 2019·0 cites·14 claims
- 4454US2010158973A1Therapeutic uses of cannabidiol compoundsHADASIT MED RES SERVICE·Filed 2007·Application pending·0 cites
- 4554US2010099756A1Uses of incensole, incensole acetate and derivatives thereofYISSUM RES DEV CO·Filed 2007·Application pending·0 cites
- 4653US2024116883A1Cannabinoid derivatives and their use the treatment of inflammation and/or pain and/or obesityYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2021·Application pending·0 cites
- 4753US2021379010A1Compositions comprising cannabinoids for use in the treatment of biofilm and conditions associated with microbial, fungal, bacterial infectionsYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2019·Application pending·0 cites
- 4851US2017029391A1Cyclohexenyl compounds, compositions comprising them and methodsYISSUM RES DEV CO·Filed 2016·Application pending·0 cites
- 4948US2022110901A1Fatty acid amides and uses thereof in the treatment of nauseaPARKER LINDA·Filed 2021·Application pending·0 cites
- 5047US2013190393A1Uses of incensole, incensole acetate and derivatives thereofHEBREW UNIVERSITY OF JERUSALEM LTD YISSUM RES DEV COMPANY OF THE·Filed 2012·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Raphael Mechoulam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →